The results of the research may help advance patient-specific hematopoietic stem/progenitor cells and produce more individualized blood products for cell-replacement therapy. Should the researchers identify how to program stem cells to the needs of specific patients, they could help treat diseases such as leukemia, lymphomas, multiple myeloma and immune deficiency.
“To cure disease in the long-term, we need to be able to transplant something that can keep producing new blood cells and won’t be rejected by the patient’s body,” said senior author of the study, Kateri Moore, DVM.
This study has gotten Mount Sinai one step closer to that goal. To learn more, click here.
More articles on stem cell research:
Can stem cells heal tissue damage from heart attacks? UMass researchers want to find out
Leukemia patients at high risk for C. diff infections, study finds
16 scientific, health issues with the greatest political divide
